Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02216604
• Date of registration: 13/08/2014
• Prospective Registration: No
• Primary sponsor: German Cancer Research Center
• Public title: Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment ONKOKIDS-HD
• Scientific title: Physical Activity Intervention Program for Childhood Cancer Patients Under Chemo- and/or Radiation Therapy
• Date of first enrolment: May 2011
• Target sample size: 50
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02216604
• Study type: Interventional
• Study design: Allocation: Non-Randomized. Intervention model: Factorial Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Germany

Contacts

• Name: Joachim Wiskemann, PhD
• Affiliation: National Center for Tumor Diseases

Key inclusion & exclusion criteria

Inclusion Criteria:

- pediatric cancer diagnosis (primary leukemia, brain tumors and bone tumors

- date of diagnosis not longer than 8 weeks ago

Exclusion Criteria:

- severe cardiac impairment

- bone metastasis inducing skeletal fragility

- other orthopedic diseases or any other circumstance that would impede ability to give
informed consent or adherence to study requirements.



Age minimum: 5 Years
Age maximum: 21 Years
Gender: All

Health Condition(s) or Problem(s) studied

Childhood Cancer

Intervention(s)

Behavioral: Multimodal Exercise Intervention

Primary Outcome(s)

Feasibility after 6 month [Time Frame: after primary treatment (6 month)]

Secondary Outcome(s)

Feasibility between 6 and 12 month [Time Frame: between end of primary treatment (6 month) and one year]

Physical performance [Time Frame: after primary treatment (6 month) and after one year]

Quality of Life [Time Frame: after primary treatment (6 month) and after one year]

Secondary ID(s)

S105-2011

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University Hospital Heidelberg

Children's Medical Hospital, University of Leipzig, Leipzig, Germany

Heidelberg University

University of Leipzig